The consequences of prostate cancer metastasis remain severe, with huge impact on the
mortality and overall quality of life of affected patients. Despite the convoluted interplay and …

Prostate cancer (PC) is the most common cancer in men and the second leading cause of
cancer-related death worldwide. Many therapeutic advances over the last two decades have …

Vascular endothelial growth factor-2 (VEGFR-2) is considered one of the most important
factors in tumor angiogenesis, and consequently a number of anticancer therapeutics have …

Purpose A randomized, placebo-controlled study based on preclinical and clinical data that
supports the potential role of vascular endothelial growth factor in prostate cancer was …

PURPOSE: Angiogenesis, a process fundamental to tumor growth, is regulated by
angiogenic factors. This article reviews prognostic and other clinical implications of …

Since the NF-κB/relA transcription factor is constitutively activated in human prostate cancer
cells, we determined whether blocking NF-κB/relA activity in human prostate cancer cells …

Background: Vascular endothelial growth factor (VEGF) is an important regulator of
angiogenesis. Strong interindividual variations of VEGF plasma levels have been reported …

Prostate cancer is the most commonly diagnosed cancer among men in the Western world.
Although localized disease can be effectively treated with established surgical and …

The assessment of angiogenesis in breast cancer is of importance as a key indicator of
survival and response to therapy. Circulating vascular endothelial growth factor (VEGF) …

Obesity is known to have important roles in driving prostate cancer aggressiveness and
increased mortality. Multiple mechanisms have been postulated for these clinical …